BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25504230)

  • 21. Direct Technetium radiopharmaceuticals production using a 30MeV Cyclotron.
    Jalilian A; Targholizadeh H; Raisali G; Zandi H; Kamali Dehgan M
    Daru; 2011; 19(3):187-92. PubMed ID: 22615656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybridised production of technetium-99m and technetium-101 with fluorine-18 on a low-energy biomedical cyclotron.
    Johnstone EV; Mayordomo N; Mausolf EJ
    EPJ Tech Instrum; 2023; 10(1):1. PubMed ID: 36817092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the experimental yield of
    Bondar BM; Leshchenko BY; Kadenko IM; Kmetyuk YV
    Appl Radiat Isot; 2022 Nov; 189():110431. PubMed ID: 36122547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The excitation functions of (100)Mo(p,x)(99)Mo and (100)Mo(p,2n)(99m)Tc.
    Manenti S; Holzwarth U; Loriggiola M; Gini L; Esposito J; Groppi F; Simonelli F
    Appl Radiat Isot; 2014 Dec; 94():344-348. PubMed ID: 25305527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future of low specific activity molybdenum-99/technetium-99m generator.
    Mushtaq A
    Curr Radiopharm; 2012 Oct; 5(4):325-8. PubMed ID: 22642420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.
    Martini P; Boschi A; Cicoria G; Zagni F; Corazza A; Uccelli L; Pasquali M; Pupillo G; Marengo M; Loriggiola M; Skliarova H; Mou L; Cisternino S; Carturan S; Melendez-Alafort L; Uzunov NM; Bello M; Alvarez CR; Esposito J; Duatti A
    Appl Radiat Isot; 2018 Sep; 139():325-331. PubMed ID: 29936404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)Tc.
    Cutler CS; Schwarz SW
    J Nucl Med; 2014 Jul; 55(7):1208-13. PubMed ID: 24854794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Ways to Address Shortage Situations of
    Filzen LM; Ellingson LR; Paulsen AM; Hung JC
    J Nucl Med Technol; 2017 Mar; 45(1):1-5. PubMed ID: 28154015
    [No Abstract]   [Full Text] [Related]  

  • 29. 99Mo/(99m)Tc separation: an assessment of technology options.
    Dash A; Knapp FF; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):167-76. PubMed ID: 23142410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of alternative production routes of 99mTc: deuteron induced reactions on 100 Mo.
    Tárkányi F; Hermanne A; Takács S; Sonck M; Szucs Z; Király B; Ignatyuk AV
    Appl Radiat Isot; 2011 Jan; 69(1):18-25. PubMed ID: 20817541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of 99mTc from Na2[99Mo]MoO4 solution obtained from reactor-produced (n,gamma) 99Mo using a tiny Dowex-1 column in tandem with a small alumina column.
    Chattopadhyay S; Das SS; Das MK; Goomer NC
    Appl Radiat Isot; 2008 Dec; 66(12):1814-7. PubMed ID: 18703342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production scheme for diagnostic-therapeutic radioisotopes by accelerator neutrons.
    Nagai Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(6):292-323. PubMed ID: 34121042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative description of the compatibility of technetium-selective chromatographic technetium-99m separation with low specific activity molybdenum-99.
    Jang J; Sekimoto S; Ohtsuki T; Tatenuma K; Tsuguchi A; Uesaka M
    J Chromatogr A; 2023 Aug; 1705():464192. PubMed ID: 37459808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
    Chakravarty R; Ram R; Dash A; Pillai MR
    Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Feasibility of Mo-99/Tc-99m production by using countrywide cyclotrons as an alternative].
    Nagatsu K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(4):484-90. PubMed ID: 22516601
    [No Abstract]   [Full Text] [Related]  

  • 36. An automated module for the separation and purification of cyclotron-produced 99mTcO4-.
    Morley TJ; Dodd M; Gagnon K; Hanemaayer V; Wilson J; McQuarrie SA; English W; Ruth TJ; Bénard F; Schaffer P
    Nucl Med Biol; 2012 May; 39(4):551-9. PubMed ID: 22226026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A strategy for intensive production of molybdenum-99 isotopes for nuclear medicine using CANDU reactors.
    Morreale AC; Novog DR; Luxat JC
    Appl Radiat Isot; 2012 Jan; 70(1):20-34. PubMed ID: 21816619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graphical user interface for yield and dose estimations for cyclotron-produced technetium.
    Hou X; Vuckovic M; Buckley K; Bénard F; Schaffer P; Ruth T; Celler A
    Phys Med Biol; 2014 Jul; 59(13):3337-52. PubMed ID: 24874744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of (99m)Tc from a commercial (99)Mo/(99m)Tc generator as yield tracer for the determination of (99)Tc at low levels.
    Hou X; Jensen M; Nielsen SP
    Appl Radiat Isot; 2007 May; 65(5):610-8. PubMed ID: 17350274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel electrochemical technique for the production of clinical grade 99mTc using (n, gamma)99Mo.
    Chakravarty R; Dash A; Venkatesh M
    Nucl Med Biol; 2010 Jan; 37(1):21-8. PubMed ID: 20122664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.